Published in Radiology on February 04, 2005
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Screening in the dark: ethical considerations of providing screening tests to individuals when evidence is insufficient to support screening populations. Am J Bioeth (2009) 5.89
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83
Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med (2013) 4.64
Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst (2010) 2.50
5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest (2009) 2.45
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology (2008) 2.37
The Lung Image Database Consortium (LIDC) data collection process for nodule detection and annotation. Acad Radiol (2007) 2.15
Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med (2011) 2.05
Computer-aided diagnosis of pulmonary nodules on CT scans: segmentation and classification using 3D active contours. Med Phys (2006) 2.03
Significance of non-calcified pulmonary nodules in patients with extrapulmonary cancers. Thorax (2006) 1.86
Lung cancer screening. Br J Cancer (2010) 1.57
Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects. Eur Radiol (2008) 1.56
Clinical validation of an autoantibody test for lung cancer. Ann Oncol (2010) 1.55
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays. Tumour Biol (2012) 1.52
Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer (2009) 1.44
Computer-aided diagnosis of pulmonary nodules on CT scans: improvement of classification performance with nodule surface features. Med Phys (2009) 1.39
Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer (2008) 1.26
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest (2015) 1.16
Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC. Int J Mol Sci (2013) 1.15
Effect of CT scanning parameters on volumetric measurements of pulmonary nodules by 3D active contour segmentation: a phantom study. Phys Med Biol (2008) 1.14
Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY)--a pilot study. J Thorac Oncol (2013) 1.13
CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort. PLoS One (2012) 1.12
Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. J Clin Oncol (2013) 1.08
Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer. Mod Pathol (2008) 1.07
Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Cancer Epidemiol Biomarkers Prev (2012) 1.04
Pulmonary nodule characterization: a comparison of conventional with quantitative and visual semi-quantitative analyses using contrast enhancement maps. Eur J Radiol (2006) 1.04
Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials. J Thorac Oncol (2010) 1.03
Deformable registration of the inflated and deflated lung in cone-beam CT-guided thoracic surgery: initial investigation of a combined model- and image-driven approach. Med Phys (2013) 1.02
CT-guided percutaneous transthoracic localization of pulmonary nodules prior to video-assisted thoracoscopic surgery using barium suspension. Korean J Radiol (2012) 1.02
Management of an incidentally discovered pulmonary nodule. Eur Radiol (2006) 1.01
Computer-aided nodule detection on digital chest radiography: validation test on consecutive T1 cases of resectable lung cancer. J Digit Imaging (2006) 1.01
Screening for lung cancer with low-dose computed tomography: a review of current status. J Thorac Dis (2013) 1.01
Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment. Cancer Prev Res (Phila) (2010) 1.01
Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Respir Res (2014) 0.98
Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging (2010) 0.98
Management strategy of solitary pulmonary nodules. J Thorac Dis (2013) 0.98
Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer. Ann Thorac Surg (2014) 0.97
European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol (2011) 0.96
Is screening for lung cancer using low dose spiral CT scanning worthwhile? Thorax (2006) 0.96
Screening tests: a review with examples. Inhal Toxicol (2014) 0.94
Application of glycoproteomics for the discovery of biomarkers in lung cancer. Proteomics Clin Appl (2012) 0.93
Evaluation of solitary pulmonary nodule detected during computed tomography examination. Pol J Radiol (2012) 0.92
Pulmonary nodule detection on MDCT images: evaluation of diagnostic performance using thin axial images, maximum intensity projections, and computer-assisted detection. Eur Radiol (2007) 0.91
Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions. Interact Cardiovasc Thorac Surg (2013) 0.91
Asbestos Surveillance Program Aachen (ASPA): initial results from baseline screening for lung cancer in asbestos-exposed high-risk individuals using low-dose multidetector-row CT. Eur Radiol (2006) 0.91
Is computed tomography follow-up of patients after lobectomy for non-small cell lung cancer of benefit in terms of survival? Interact Cardiovasc Thorac Surg (2012) 0.90
A pilot test of a combined tobacco dependence treatment and lung cancer screening program. Lung Cancer (2011) 0.90
Validation of a multiprotein plasma classifier to identify benign lung nodules. J Thorac Oncol (2015) 0.90
Could CT screening for lung cancer ever be cost effective in the United Kingdom? Cost Eff Resour Alloc (2008) 0.90
Size of solitary pulmonary nodule was the risk factor of malignancy. J Thorac Dis (2014) 0.89
Multiple marker detection in peripheral blood for NSCLC diagnosis. PLoS One (2013) 0.89
Short- and long-term lung cancer risk associated with noncalcified nodules observed on low-dose CT. Cancer Prev Res (Phila) (2014) 0.88
Relationship between tumor size and disease stage in non-small cell lung cancer. BMC Cancer (2010) 0.87
Lung cancer screening: history, current perspectives, and future directions. Arch Med Sci (2015) 0.86
Nanodelivery of MRI contrast agent enhances sensitivity of detection of lung cancer metastases. Acad Radiol (2009) 0.86
Autoantibody profiling for lung cancer screening longitudinal retrospective analysis of CT screening cohorts. PLoS One (2014) 0.86
The use of CT for screening: a national survey of radiologists' activities and attitudes. Radiology (2008) 0.85
Antibiotic use in the management of pulmonary nodules. Chest (2009) 0.85
Cancer screening: the journey from epidemiology to policy. Ann Epidemiol (2012) 0.85
Multiplexed Serum Biomarkers for the Detection of Lung Cancer. EBioMedicine (2016) 0.84
Total-body MR-imaging in oncology. Eur Radiol (2006) 0.84
Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung Test. PLoS One (2012) 0.82
Lung cancer screening with CT. Clin Chest Med (2008) 0.82
Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge. Proteomics Clin Appl (2013) 0.82
Automated sputum cytometry for detection of intraepithelial neoplasias in the lung. Anal Cell Pathol (Amst) (2012) 0.81
Ethical considerations in CT angiography. Int J Cardiovasc Imaging (2006) 0.81
Immunological thought in the mainstream of cancer research: Past divorce, recent remarriage and elective affinities of the future. Oncoimmunology (2012) 0.81
Meta-analysis of the diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules. J Thorac Dis (2015) 0.81
Localization of nonpalpable pulmonary nodules using CT-guided needle puncture. World J Surg Oncol (2015) 0.81
Lung cancer at a University Hospital in Saudi Arabia: A four-year prospective study of clinical, pathological, radiological, bronchoscopic, and biochemical parameters. Ann Thorac Med (2010) 0.80
Clinical and economic consequences of non-cardiac incidental findings detected on cardiovascular computed tomography performed prior to transcatheter aortic valve implantation (TAVI). Int J Cardiovasc Imaging (2015) 0.80
Comparing the benefits of screening for breast cancer and lung cancer using a novel natural history model. Cancer Causes Control (2011) 0.80
Lung cancer screening. Semin Intervent Radiol (2013) 0.79
Role of quantitative computed tomography texture analysis in the differentiation of primary lung cancer and granulomatous nodules. Quant Imaging Med Surg (2016) 0.79
Screening for lung cancer. Cancer Imaging (2006) 0.78
Incidental, subsolid pulmonary nodules at CT: etiology and management. Cancer Imaging (2013) 0.78
Manifestations and pathological features of solitary thin-walled cavity lung cancer observed by CT and PET/CT imaging. Oncol Lett (2014) 0.78
Preoperative CT Predicting Recurrence of Surgically Resected Adenocarcinoma of the Lung. Medicine (Baltimore) (2016) 0.78
Deformable Registration of the Inflated and Deflated Lung for Cone-Beam CT-Guided Thoracic Surgery. Proc SPIE Int Soc Opt Eng (2012) 0.78
Lung cancer screening: from imaging to biomarker. Biomark Res (2013) 0.78
Quantitative Computed Tomography Features for Predicting Tumor Recurrence in Patients with Surgically Resected Adenocarcinoma of the Lung. PLoS One (2017) 0.77
Limited value of ⁹⁹mTc depreotide single photon emission CT compared with CT for the evaluation of pulmonary lesions. Br J Radiol (2012) 0.77
MR Imaging of Pulmonary Nodules: Detection Rate and Accuracy of Size Estimation in Comparison to Computed Tomography. PLoS One (2016) 0.77
Pulmonary nodules detected by thoracic computed tomography scan after exposure to asbestos: diagnostic significance. Int J Tuberc Lung Dis (2011) 0.76
Early diagnosis of lung cancer. F1000Prime Rep (2013) 0.76
Pulmonary nodules and CT screening: the past, present and future. Thorax (2016) 0.76
Lung cancer screening: past, present and future. Clin Chest Med (2013) 0.76
Lung cancer screening: subsequent evidences of national lung screening trial. Tuberc Respir Dis (Seoul) (2014) 0.76
Ant colony optimization approaches to clustering of lung nodules from CT images. Comput Math Methods Med (2014) 0.75
eComment. Computed tomography surveillance of lung cancer survivors: the jury is still out. Interact Cardiovasc Thorac Surg (2012) 0.75
Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial. BMC Cancer (2017) 0.75
Computed tomography surveillance scanning after lung cancer surgery: mathematical optimization of scanning interval based on tumour biology. Interact Cardiovasc Thorac Surg (2013) 0.75
Roles of computed tomography and [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography in the characterization of multiple solitary solid lung nodules. Ecancermedicalscience (2012) 0.75
Data analysis: evaluation of nanoscale contrast agent enhanced CT scan to differentiate between benign and malignant lung cancer in mouse model. AMIA Annu Symp Proc (2012) 0.75
College of Radiology, Academy of Medicine of Malaysia position on whole body screening CT scans in healthy asymptomatic individuals (2008). Biomed Imaging Interv J (2008) 0.75
Clinical application of CT and CT-guided percutaneous transthoracic needle biopsy in patients with indeterminate pulmonary nodules. J Bras Pneumol (2014) 0.75
Lung cancer screening update. Cancer Imaging (2009) 0.75
Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology (2005) 9.83
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Computed tomography screening and lung cancer outcomes. JAMA (2007) 8.01
Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med (2002) 5.10
Lung cancer screening with CT: Mayo Clinic experience. Radiology (2003) 4.72
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg (2012) 4.68
Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.49
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med (2008) 3.97
Non-small-cell lung cancer. Lancet (2011) 3.45
Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology (2007) 3.44
Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest (2010) 3.13
Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutations. J Thorac Oncol (2012) 3.10
Septic pulmonary embolism: presenting features and clinical course of 14 patients. Chest (2005) 2.97
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med (2008) 2.74
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426. J Clin Oncol (2009) 2.54
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma. J Clin Oncol (2009) 2.50
Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease. Blood (2011) 2.45
5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest (2009) 2.45
The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol (2003) 2.32
Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest (2013) 2.21
Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest (2009) 2.16
Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis. J Clin Oncol (2012) 2.15
Advances in chemotherapy of non-small cell lung cancer. Chest (2006) 2.00
Commentary: CT screening for lung cancer--caveat emptor. Oncologist (2008) 1.95
Hot tub lung: presenting features and clinical course of 21 patients. Respir Med (2005) 1.89
Pulmonary embolization of 2-octyl cyanoacrylate after endoscopic injection therapy for gastric variceal bleeding. Mayo Clin Proc (2004) 1.81
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys (2004) 1.81
Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. Mayo Clin Proc (2010) 1.80
Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg (2004) 1.77
Chronic nitrofurantoin-induced lung disease. Mayo Clin Proc (2005) 1.76
Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol (2006) 1.75
Quality of life and symptom burden among long-term lung cancer survivors. J Thorac Oncol (2012) 1.74
Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. J Thorac Cardiovasc Surg (2004) 1.67
Clinical problem-solving. Occam's razor versus Saint's Triad. N Engl J Med (2004) 1.64
Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study. J Thorac Cardiovasc Surg (2011) 1.59
A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest (2006) 1.59
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology (2012) 1.58
Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med (2008) 1.57
Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668. Cancer Prev Res (Phila) (2011) 1.57
Change in smoking status after spiral chest computed tomography scan screening. Cancer (2003) 1.55
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2002) 1.55
Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials. Biometrics (2011) 1.54
Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. AJR Am J Roentgenol (2006) 1.53
Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer (2005) 1.51
A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer. Clin Cancer Res (2006) 1.51
Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors. Cancer (2007) 1.50
Mediastinal lymphangioma: Mayo Clinic experience of 25 cases. Mayo Clin Proc (2006) 1.49
Granulomatous inflammation detected by endobronchial ultrasound-guided transbronchial needle aspiration in patients with a concurrent diagnosis of cancer: a clinical conundrum. J Bronchology Interv Pulmonol (2012) 1.48
Flexible bronchoscopic management of airway foreign bodies in children. Chest (2002) 1.46
Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.43
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). Lung Cancer (2007) 1.36
Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest (2005) 1.34
Cystic lung disease in Birt-Hogg-Dube syndrome. Chest (2007) 1.34
Pulmonary cryptococcosis: CT findings in immunocompetent patients. Radiology (2005) 1.32
Inappropriate application of nodule management guidelines in radiologist reports before and after revision of exclusion criteria. AJR Am J Roentgenol (2011) 1.30
Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigation. J Clin Oncol (2010) 1.28
Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol (2005) 1.27
A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer (2006) 1.26
Cough-induced rib fractures. Mayo Clin Proc (2005) 1.23
Fibrosing mediastinitis: clinical presentation, therapeutic outcomes, and adaptive immune response. Medicine (Baltimore) (2011) 1.21
Diagnosis of interstitial lung diseases. Mayo Clin Proc (2007) 1.19
Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer (2004) 1.19
Significance of multiple carcinoid tumors and tumorlets in surgical lung specimens: analysis of 28 patients. Chest (2007) 1.19
The electronic imaging technology specialist: the role of a new radiology subspecialty for the 21st century. J Digit Imaging (2002) 1.18
Endpoints in phase II trials for advanced non-small cell lung cancer. J Thorac Oncol (2010) 1.16
The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Chest (2007) 1.16
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials. Cancer (2009) 1.15
Lack of evidence for an association between neurofibromatosis and pulmonary fibrosis. Chest (2005) 1.14
A 2-stage phase II design with direct assignment option in stage II for initial marker validation. Clin Cancer Res (2012) 1.14
A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials. Cancer (2007) 1.14
Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med (2005) 1.13
Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY)--a pilot study. J Thorac Oncol (2013) 1.13